Back to Browse Journals » International Journal of Nanomedicine » Volume 7

Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles

Authors Kumar D, Meenan BJ, Dixon D

Published Date July 2012 Volume 2012:7 Pages 4007—4022

DOI http://dx.doi.org/10.2147/IJN.S33726

Received 9 May 2012, Accepted 31 May 2012, Published 25 July 2012

Dhiraj Kumar, Brian J Meenan, Dorian Dixon

Nanotechnology and Integrated BioEngineering Centre, University of Ulster, Belfast, Northern Ireland

Abstract: Gold nanoparticles synthesized via sodium citrate reduction of chloroauric acid (HAuCl4) were functionalized with either various concentrations of thiol-terminated Bodipy® FL L-cystine (0.5, 1.0, 1.5, and 2.0 µg/mL) or Bodipy-poly(ethylene glycol) at concentrations of 0.5–18.75, 1.0–12.50, and 1.5–6.25 µg/mL to form a mixed monolayer of BODIPY-PEG. Thiol-terminated Bodipy, a fluorescing molecule, was used as the model drug, while PEG is widely used in drug-delivery applications to shield nanoparticles from unwanted immune responses. Understanding the influence of PEG-capping on payload release is critical because it is the most widely used type of nanoparticle functionalization in drug delivery studies. It has been previously reported that glutathione can trigger release of thiol-bound payloads from gold nanoparticles. Bodipy release from Bodipy capped and from Bodipy-PEG functionalized gold nanoparticles was studied at typical intracellular glutathione levels. It was observed that the addition of PEG capping inhibits the initial burst release observed in gold nanoparticles functionalized only with Bodipy and inhibits nanoparticle aggregation. Efficient and controlled payload release was observed in gold nanoparticles cofunctionalized with only a limited amount of PEG, thus enabling the coattachment of large amounts of drug, targeting groups or other payloads.

Keywords: gold nanoparticles, FL L-cystine, Bodipy®, poly(ethylene glycol), glutathione-mediated release, photoluminescence

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Functionalized graphene oxide for clinical glucose biosensing in urine and serum samples

Veerapandian M, Seo YT, Shin H, Yun K, Lee MH

International Journal of Nanomedicine 2012, 7:6123-6136

Published Date: 18 December 2012

The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)

Amal H, Ding L, Liu BB, Tisch U, Xu ZQ, Shi DY, Zhao Y, Chen J, Sun RX, Liu H, Ye SL, Tang ZY, Haick H

International Journal of Nanomedicine 2012, 7:4135-4146

Published Date: 30 July 2012

Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy

Gao X, Luo Y, Wang Y, Pang J, Liao C, Lu H, Fang Y

International Journal of Nanomedicine 2012, 7:4037-4051

Published Date: 30 July 2012

Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine

Chen J, Yan GJ, Hu RR, Gu QW, Chen ML, Gu W, Chen ZP, Cai BC

International Journal of Nanomedicine 2012, 7:3567-3577

Published Date: 26 July 2012

Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability

Luo H, Jiang B, Li B, Li Z, Jiang BH, Chen YC

International Journal of Nanomedicine 2012, 7:3951-3959

Published Date: 24 July 2012

Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes

Tan QY, Zhang JQ, Wang N, Yang H, Li X, Xiong HR, Wu JY, Zhao CJ, Wang H, Yin HF

International Journal of Nanomedicine 2012, 7:3929-3938

Published Date: 23 July 2012

Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains

Azam A, Ahmed AS, Oves M, Khan MS, Memic A

International Journal of Nanomedicine 2012, 7:3527-3535

Published Date: 10 July 2012

A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants

Xu A, Yao M, Xu G, Ying J, Ma W, Li B, Jin Y

International Journal of Nanomedicine 2012, 7:3547-3554

Published Date: 10 July 2012

Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes

Pang Z, Gao H, Chen J, Shen S, Zhang B, Ren J, Guo L, Qian Y, Jiang X, Mei H

International Journal of Nanomedicine 2012, 7:3421-3432

Published Date: 6 July 2012

A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution

Ma M, Hao Y, Liu N, Yin Z, Wang L, Liang X, Zhang X

International Journal of Nanomedicine 2012, 7:3389-3398

Published Date: 4 July 2012